43 related articles for article (PubMed ID: 22215841)
1. Prevention of bronchiolitis obliterans-the realization of a hope?
Cascalho M
J Heart Lung Transplant; 2017 Feb; 36(2):132-133. PubMed ID: 27667135
[No Abstract] [Full Text] [Related]
2. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
[TBL] [Abstract][Full Text] [Related]
3. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
[TBL] [Abstract][Full Text] [Related]
4. What we expected all along: Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplantation!
Benden C
J Heart Lung Transplant; 2015 Apr; 34(4):501-2. PubMed ID: 25727772
[No Abstract] [Full Text] [Related]
5. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
7. Montelukast for bronchiolitis obliterans syndrome after lung transplantation.
Simons SO; Reijers MH
Chest; 2012 Jan; 141(1):275-276. PubMed ID: 22215841
[No Abstract] [Full Text] [Related]
8. [Post-lung transplantation bronchiolitis obliterans].
Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans after lung transplantation: a review.
Boehler A; Kesten S; Weder W; Speich R
Chest; 1998 Nov; 114(5):1411-26. PubMed ID: 9824023
[No Abstract] [Full Text] [Related]
10. Circumstances of bronchiolitis obliterans development after lung transplantation: analysis of risk factors.
Pereszlenyi A; Harustiak S; Klepetko W
Bratisl Lek Listy; 2000; 101(12):633-8. PubMed ID: 11723655
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
